Parnell Pharmaceuticals Holdings - 53 Year Dividend History | PARNF

Historical dividend payout and yield for Parnell Pharmaceuticals Holdings (PARNF) since 1972. The current TTM dividend payout for Parnell Pharmaceuticals Holdings (PARNF) as of April 22, 2025 is $0.00. The current dividend yield for Parnell Pharmaceuticals Holdings as of April 22, 2025 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Parnell Pharmaceuticals Holdings Ltd. is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing animal health solutions. It manufactures and markets cattle reproduction, cattle mastitis, anesthetics, laminitis treatment, and orthopedic treatment products. The Company operates in four segments: Companion Animal, Production Animal-Unites States, and Production Animal-rest of the world and Manufacturing Operations. ZYDAX (R), GLYDE (R) and TERGIVE (R) are Parnell's premium osteoarthritis product suite. Parnell Pharmaceuticals Holdings Ltd. is headquartered in Alexandria, Australia.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.246B 6.88
Dr Reddy's Laboratories (RDY) India $12.288B 22.30
BridgeBio Pharma (BBIO) United States $6.503B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.775B 14.41
Bausch Health Cos (BHC) Canada $1.656B 1.21
Amphastar Pharmaceuticals (AMPH) United States $1.212B 8.14
Taysha Gene Therapies (TSHA) United States $0.582B 0.00
Personalis (PSNL) United States $0.409B 0.00
Assembly Biosciences (ASMB) United States $0.108B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00